Literature DB >> 22344407

Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an α-synuclein-dependent mechanism.

Heramb Chadchankar1, Jouni Ihalainen, Heikki Tanila, Leonid Yavich.   

Abstract

Methylphenidate (MPD) modulates dopamine (DA) overflow in part by redistributing vesicle pools, a function shared by the presynaptic protein α-synuclein (α-syn). We suggest that α-syn modifies the effect of MPD on DA neurotransmission. The effect was studied in the dorsal striatum in wild-type mice and two mouse lines lacking α-syn by using in vivo voltammetry and microdialysis. MPD (1 mg/kg) attenuated evoked DA overflow only in mice lacking α-syn but produced a similar increase in the extracellular DA levels in all three lines. A kinetic analysis showed that MPD decreased DA release per stimulus pulse in α-syn-deficient mice but increased in wild-type mice. MPD blocked DA reuptake and produced a similar increase in the apparent affinity (K(m)) for DA reuptake in all three lines. Repeated-burst stimulation redistributes vesicular storage pools and facilitates DA overflow, and this form of facilitation is significantly enhanced in α-syn knockout mice. The DA reuptake inhibitor 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) (10 mg/kg) completely blocked the facilitation of DA overflow in all three lines, whereas MPD (1 mg/kg) selectively decreased it only in mice lacking α-syn. MPD (5 mg/kg) and GBR12909 (10 mg/kg) produced equipotent inhibition of DA reuptake (in terms of K(m)), indicating that reuptake inhibition does not explain the MPD selectivity. Our data indicate that MPD decreases DA release probability in the absence of α-syn and increases it in control animals, whereas the effect of MPD on DA reuptake is independent of α-syn. We suggest that this selectivity is based on α-syn-dependent compartmentalization of presynaptic DA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22344407     DOI: 10.1124/jpet.111.189225

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Modafinil Activates Phasic Dopamine Signaling in Dorsal and Ventral Striata.

Authors:  Martin J Bobak; Matthew W Weber; Melissa A Doellman; Douglas R Schuweiler; Jeana M Athens; Steven A Juliano; Paul A Garris
Journal:  J Pharmacol Exp Ther       Date:  2016-10-12       Impact factor: 4.030

2.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.

Authors:  Erin S Calipari; Sara R Jones
Journal:  Neuropharmacology       Date:  2014-03-13       Impact factor: 5.250

Review 3.  Illicit dopamine transients: reconciling actions of abused drugs.

Authors:  Dan P Covey; Mitchell F Roitman; Paul A Garris
Journal:  Trends Neurosci       Date:  2014-03-20       Impact factor: 13.837

4.  Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.

Authors:  Alicia J Avelar; Steven A Juliano; Paul A Garris
Journal:  J Neurochem       Date:  2013-03-06       Impact factor: 5.372

5.  Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.

Authors:  Jordan T Yorgason; Erin S Calipari; Mark J Ferris; Anushree N Karkhanis; Steven C Fordahl; Jeffrey L Weiner; Sara R Jones
Journal:  Neuropharmacology       Date:  2015-10-23       Impact factor: 5.250

6.  Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.

Authors:  D P Daberkow; H D Brown; K D Bunner; S A Kraniotis; M A Doellman; M E Ragozzino; P A Garris; M F Roitman
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

7.  Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.

Authors:  Erin S Calipari; Mark J Ferris; Cody A Siciliano; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2014-12-18       Impact factor: 4.418

8.  Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.

Authors:  Andrea Casiraghi; Francesca Longhena; Gaia Faustini; Giovanni Ribaudo; Lorenzo Suigo; Gisela Andrea Camacho-Hernandez; Federica Bono; Viviana Brembati; Amy Hauck Newman; Alessandra Gianoncelli; Valentina Straniero; Arianna Bellucci; Ermanno Valoti
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

9.  Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.

Authors:  Maurício dos Santos Pereira; Matheus Figueiredo Sathler; Thais da Rosa Valli; Richard Souza Marques; Ana Lucia Marques Ventura; Ney Ronner Peccinalli; Mabel Carneiro Fraga; Alex C Manhães; Regina Kubrusly
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.